FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 220 filers reported holding FIBROGEN INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $327,000 | -8.9% | 9,435 | -2.5% | 0.01% | -16.7% |
| Q4 2020 | $359,000 | -48.1% | 9,678 | -42.5% | 0.01% | -53.8% |
| Q3 2020 | $692,000 | +47.2% | 16,819 | +44.9% | 0.01% | +30.0% |
| Q2 2020 | $470,000 | +17.5% | 11,606 | +0.8% | 0.01% | 0.0% |
| Q1 2020 | $400,000 | -20.3% | 11,511 | -1.7% | 0.01% | -9.1% |
| Q4 2019 | $502,000 | +29.4% | 11,716 | +11.6% | 0.01% | +22.2% |
| Q3 2019 | $388,000 | -19.7% | 10,498 | -1.9% | 0.01% | -18.2% |
| Q2 2019 | $483,000 | -8.9% | 10,697 | +9.7% | 0.01% | -8.3% |
| Q1 2019 | $530,000 | +124.6% | 9,752 | +158.9% | 0.01% | +100.0% |
| Q2 2018 | $236,000 | -0.4% | 3,767 | -14.6% | 0.01% | 0.0% |
| Q4 2017 | $237,000 | 0.0% | 4,410 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $237,000 | +253.7% | 4,410 | +112.6% | 0.01% | +200.0% |
| Q2 2017 | $67,000 | -19.3% | 2,074 | -38.7% | 0.00% | 0.0% |
| Q1 2017 | $83,000 | – | 3,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 305,784 | $8,143,000 | 8.63% |
| Vantage Consulting Group Inc | 605,713 | $16,130,000 | 2.81% |
| GREAT POINT PARTNERS LLC | 500,000 | $13,315,000 | 2.79% |
| HHLR ADVISORS, LTD. | 3,955,787 | $105,343,000 | 1.08% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $5,094,000 | 1.01% |
| Ikarian Capital, LLC | 250,000 | $6,657,000 | 0.54% |
| BHK Investment Advisors, LLC | 45,100 | $1,201,000 | 0.49% |
| Ikarian Capital, LLC | 193,800 | $5,161,000 | 0.42% |
| Omega Fund Management, LLC | 130,646 | $3,479,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 200,000 | $5,326,000 | 0.36% |